77 related articles for article (PubMed ID: 1466960)
1. Oral priming followed by parenteral immunization with HIV-immunosomes induce HIV-1-specific salivary and circulatory IgA in mice and rabbits.
Thibodeau L; Tremblay C; Lachapelle L
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1379. PubMed ID: 1466960
[No Abstract] [Full Text] [Related]
2. [Oral and parenteral immunization with HIV immunosome induce the secretion of IgA specific of HIV-1 in the salivary and the production of circulatory IgA in mice and rabbits].
Thibodeau L; Tremblay C; Lachapelle L
C R Acad Sci III; 1991; 313(9):389-94. PubMed ID: 1756412
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.
Mosier DE; Gulizia RJ; MacIsaac P; Mathieson BJ; Smith G; Hu SL; Corey L; Greenberg P
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1387. PubMed ID: 1466962
[No Abstract] [Full Text] [Related]
4. HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.
Gorse GJ; Rogers JH; Perry JE; Newman FK; Frey SE; Patel GB; Belshe RB
Vaccine; 1995 Feb; 13(2):209-14. PubMed ID: 7625118
[TBL] [Abstract][Full Text] [Related]
5. Production in rabbits of high levels of anti-HIV-1 gp160 antibodies.
Relyveld E; Bizzini B
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):389-93. PubMed ID: 7580832
[TBL] [Abstract][Full Text] [Related]
6. Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160.
Vasudevachari MB; Uffelman KW; Kovacs J; Yeh CK; Lane HC; Salzman NP
J Acquir Immune Defic Syndr (1988); 1992; 5(8):817-21. PubMed ID: 1517967
[TBL] [Abstract][Full Text] [Related]
7. Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children.
Archibald DW; Johnson JP; Nair P; Alger LS; Hebert CA; Davis E; Hines SE
AIDS; 1990 May; 4(5):417-20. PubMed ID: 2196908
[TBL] [Abstract][Full Text] [Related]
8. Practical applications for saliva in perinatal HIV diagnosis.
Archibald DW; Farley JJ; Hebert CA; Hines SE; Nair P; Johnson JP
Ann N Y Acad Sci; 1993 Sep; 694():195-201. PubMed ID: 8215055
[No Abstract] [Full Text] [Related]
9. Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus.
Klaniecki J; Dykers T; Travis B; Schmitt R; Wain M; Watson A; Sridhar P; McClure J; Morein B; Ulrich JT
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):791-8. PubMed ID: 1742074
[TBL] [Abstract][Full Text] [Related]
10. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.
Sun D; Archibald DW; Furth PA
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immun 1994;98:178-84.
DePalma L
Pediatr AIDS HIV Infect; 1995 Apr; 6(2):97-8. PubMed ID: 11361387
[No Abstract] [Full Text] [Related]
12. Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Nixon A; Zaghouani H; Penney CL; Lacroix M; Dionne G; Anderson SA; Kennedy RC; Bona CA
Viral Immunol; 1992; 5(2):141-50. PubMed ID: 1616585
[TBL] [Abstract][Full Text] [Related]
13. Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial.
Archibald DW; Hebert CA; Sun D; Tacket CO
J Acquir Immune Defic Syndr (1988); 1990; 3(10):954-8. PubMed ID: 2204698
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations.
Graham BS
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1327-8. PubMed ID: 1466951
[No Abstract] [Full Text] [Related]
15. Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Bona C; Nixon A; Kennedy R; Zaghouani H
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1377. PubMed ID: 1466959
[No Abstract] [Full Text] [Related]
16. Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages.
Matsuda S; Oka S; Honda M; Takebe Y; Takemori T
Scand J Immunol; 1993 Nov; 38(5):428-34. PubMed ID: 8235446
[TBL] [Abstract][Full Text] [Related]
17. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.
Hosmalin A; Nara PL; Zweig M; Lerche NW; Cease KB; Gard EA; Markham PD; Putney SD; Daniel MD; Desrosiers RC
J Immunol; 1991 Mar; 146(5):1667-73. PubMed ID: 1704401
[TBL] [Abstract][Full Text] [Related]
18. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
[No Abstract] [Full Text] [Related]
19. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.
Lü XS; Delfraissy JF; Grangeot-Keros L; Rannou MT; Pillot J
Res Virol; 1994; 145(6):369-77. PubMed ID: 7709073
[TBL] [Abstract][Full Text] [Related]
20. High-titer HIV-1 neutralizing antibody response of rhesus macaques to gp160 and env peptides.
Ronco J; Dedieu JF; Marie FN; Pinter A; Kaczorek M; Girard M
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1117-23. PubMed ID: 1503824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
